Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Condensed Consolidated Statements of Operations and Comprehensive Loss [Abstract]
Net sales	$ 1,725	$ 2,194	$ 3,629	$ 4,051
Cost of goods sold	767	720	1,604	1,386
Gross profit	958	1,474	2,025	2,665
Operating expenses:
Selling, general and administrative	3,189	3,236	6,766	7,842
Research and development	675	558	1,225	1,892
Total operating expenses	3,864	3,794	7,991	9,734
Loss from operations	(2,906)	(2,320)	(5,966)	(7,069)
Other income (expense), net	10	6	17	(95)
Financing expense	(10,553)	(5,607)	(10,553)	(5,607)
Change in fair value of warrant liabilities	900	198	940	720
Loss before income taxes	(12,549)	(7,723)	(15,562)	(12,051)
Income tax expense	(4)	(2)	(5)	(4)
Net loss	(12,553)	(7,725)	(15,567)	(12,055)
Deemed dividend attributable to Series J Convertible Preferred Stock	1	0	2	541
Net loss attributable to common shareholders	$ (12,552)	$ (7,725)	$ (15,565)	$ (11,514)
Basic loss per share (in Dollars per share)	$ (60.99)	$ (791.82)	$ (100.44)	$ (139.74)
Diluted loss per share (in Dollars per share)	$ (60.99)	$ (791.82)	$ (100.44)	$ (139.74)
Weighted average shares outstanding – basic (in Shares)	205,839	9,755	154,991	86,261
Weighted average shares outstanding – diluted (in Shares)	205,839	9,755	154,991	86,261
Other comprehensive loss:
Net Loss	$ (12,553)	$ (7,725)	$ (15,567)	$ (12,055)
Foreign currency translation adjustments	(5)	(2)	(7)	(11)
Total comprehensive loss	$ (12,558)	$ (7,727)	$ (15,574)	$ (12,066)